These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 29902603

  • 1. Endoscopic Endonasal Approach to the Growth Hormone-Secreting Pituitary Adenomas: Endocrinologic Outcome in 68 Patients.
    Taghvaei M, Sadrehosseini SM, Ardakani JB, Nakhjavani M, Zeinalizadeh M.
    World Neurosurg; 2018 Sep; 117():e259-e268. PubMed ID: 29902603
    [Abstract] [Full Text] [Related]

  • 2. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
    Cardinal T, Rutkowski MJ, Micko A, Shiroishi M, Jason Liu CS, Wrobel B, Carmichael J, Zada G.
    Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
    [Abstract] [Full Text] [Related]

  • 3. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
    Hofstetter CP, Mannaa RH, Mubita L, Anand VK, Kennedy JW, Dehdashti AR, Schwartz TH.
    Neurosurg Focus; 2010 Oct; 29(4):E6. PubMed ID: 20887131
    [Abstract] [Full Text] [Related]

  • 4. Endoscopic Transsphenoidal Approach for Acromegaly with Remission Rates in 401 Patients: 2010 Consensus Criteria.
    Anik I, Cabuk B, Gokbel A, Selek A, Cetinarslan B, Anik Y, Ceylan S.
    World Neurosurg; 2017 Dec; 108():278-290. PubMed ID: 28887283
    [Abstract] [Full Text] [Related]

  • 5. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas.
    Campbell PG, Kenning E, Andrews DW, Yadla S, Rosen M, Evans JJ.
    Neurosurg Focus; 2010 Oct; 29(4):E5. PubMed ID: 20887130
    [Abstract] [Full Text] [Related]

  • 6. Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas.
    Hofstetter CP, Shin BJ, Mubita L, Huang C, Anand VK, Boockvar JA, Schwartz TH.
    Neurosurg Focus; 2011 Apr; 30(4):E10. PubMed ID: 21456921
    [Abstract] [Full Text] [Related]

  • 7. Outcomes of Aggressive Surgical Resection in Growth Hormone-Secreting Pituitary Adenomas with Cavernous Sinus Invasion.
    Park HH, Kim EH, Ku CR, Lee EJ, Kim SH.
    World Neurosurg; 2018 Sep; 117():e280-e289. PubMed ID: 29906579
    [Abstract] [Full Text] [Related]

  • 8. Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature.
    Almeida JP, Ruiz-Treviño AS, Liang B, Omay SB, Shetty SR, Chen YN, Anand VK, Grover K, Christos P, Schwartz TH.
    J Neurosurg; 2018 Aug; 129(2):404-416. PubMed ID: 28862548
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of Microsurgical Sublabial Approach (MSA) Versus Endoscopic Endonasal Approach (EEA) for the Treatment of Pituitary Adenomas Based on Radiological and Hormonal Outcome.
    Mattogno PP, Mangiola A, Lofrese G, Vigo V, Anile C.
    Acta Neurochir Suppl; 2017 Aug; 124():101-106. PubMed ID: 28120060
    [Abstract] [Full Text] [Related]

  • 10. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
    Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Ferraz T.
    Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
    [Abstract] [Full Text] [Related]

  • 11. Transsphenoidal surgery for pituitary adenomas in pediatric patients: a multicentric retrospective study.
    Locatelli D, Veiceschi P, Castelnuovo P, Tanriover N, Evliyaoglu O, Canaz H, Ugurlar D, Gazioglu N.
    Childs Nerv Syst; 2019 Nov; 35(11):2119-2126. PubMed ID: 31079182
    [Abstract] [Full Text] [Related]

  • 12. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
    Taweesomboonyat C, Oearsakul T.
    World Neurosurg; 2021 Feb; 146():e1360-e1366. PubMed ID: 33309643
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Endoscopic Endonasal Surgery for Tumors of the Cavernous Sinus: A Series of 234 Patients.
    Koutourousiou M, Vaz Guimaraes Filho F, Fernandez-Miranda JC, Wang EW, Stefko ST, Snyderman CH, Gardner PA.
    World Neurosurg; 2017 Jul; 103():713-732. PubMed ID: 28450229
    [Abstract] [Full Text] [Related]

  • 15. Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection.
    Juraschka K, Khan OH, Godoy BL, Monsalves E, Kilian A, Krischek B, Ghare A, Vescan A, Gentili F, Zadeh G.
    J Neurosurg; 2014 Jul; 121(1):75-83. PubMed ID: 24785323
    [Abstract] [Full Text] [Related]

  • 16. Endoscopic Endonasal Approach for Adrenocorticotropic Hormone-Secreting Pituitary Adenomas: Outcomes and Analysis of Remission Rates and Tumor Biochemical Activity with Respect to Tumor Invasiveness.
    Shin SS, Gardner PA, Ng J, Faraji AH, Agarwal N, Chivukula S, Fernandez-Miranda JC, Snyderman CH, Challinor SM.
    World Neurosurg; 2017 Jun; 102():651-658.e1. PubMed ID: 26252984
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intraoperative Scoring System to Predict Postoperative Remission in Endoscopic Endonasal Transsphenoidal Surgery for Growth Hormone-Secreting Pituitary Adenomas.
    Yano S, Shinojima N, Kawashima J, Kondo T, Hide T.
    World Neurosurg; 2017 Sep; 105():375-385. PubMed ID: 28602880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.